Literature DB >> 17458690

Transesophageal echocardiography: a follow-up tool after catheter ablation of atrial fibrillation and interventional therapy of pulmonary vein stenosis and occlusion.

Carsten Schneider1, Sabine Ernst, Rainer Malisius, Edda Bahlmann, Friedrun Lampe, Thomas Broemel, Korff Krause, Sigrid Boczor, Matthias Antz, Karl-Heinz Kuck.   

Abstract

BACKGROUND: Pulmonary vein stenosis (PVS) has been described as a complication after primary catheter ablation of atrial fibrillation (Afib). The purpose of this study was to evaluate the utility of transesophageal echocardiography (TEE) as follow-up tool after catheter ablation of Afib and interventional therapy of PVS and pulmonary vein occlusion (PVO).
METHODS: We report on 28 patients with stenosis (PVS) of 33 pulmonary veins (PVs) and total PVO of 4 veins complicating ablation of Afib assessed by angiography and/or magnetic resonance imaging (MRI). Subsequently, transseptal PV angiograms were performed, followed by recanalization of three totally occluded PVs and balloon dilatation of seven severe PVS (in four cases combined with PV stenting). PVs were analyzed by multiplane TEE in an intraindividual comparison of preablation/preintervention and follow-up measurements of mean and peak flow velocity, velocity time integrals, and diameters.
RESULTS: Of a total of 28 patients, 14 had mild PVS (n = 14), 9 had moderate PVS (n = 10), 6 had severe PVS (n = 8), and 4 patients showed totally occluded PVs (n = 4). In multivariate analysis flow velocities and vessel diameters showed significant differences (mild, moderate, and severe PVS and PVO; p = 0.001). Interventional benefits of balloon dilatation (n = 10) and stent implantation (n = 4), as well as in-stent restenosis could be detected (p = 0.014). In all recanalized vessels TEE showed reestablished flow. In occluded PVs no flow was detectable. The TEE vessel diameters correlated with angiography data (r = 0.87) and computed tomography/MRI (r = 0.90).
CONCLUSIONS: TEE can be used as a follow-up tool after interventional therapy in patients after catheter ablation and acquired PVS/PVO. Restenosis/in-stent restenosis can be identified by analyzing the vessel diameters and blood flow characteristics.

Entities:  

Mesh:

Year:  2007        PMID: 17458690     DOI: 10.1007/s10840-007-9085-1

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.759


  38 in total

1.  Left upper pulmonary vein stenosis 2 months after radiofrequency catheter ablation of atrial fibrillation.

Authors:  R H Sohn; N B Schiller
Journal:  Circulation       Date:  2000-04-04       Impact factor: 29.690

2.  Editorial comment: can we avoid pulmonary vein stenosis following ablation of atrial fibrillation?

Authors:  S A Chen; W C Yu; C T Tai
Journal:  J Interv Card Electrophysiol       Date:  2000-12       Impact factor: 1.900

3.  Sixteen-row multislice computed tomography in the assessment of pulmonary veins prior to ablative treatment: validation vs conventional pulmonary venography and study of reproducibility.

Authors:  Ruzica Maksimović; Filippo Cademartiri; Marcoen Scholten; Luc J Jordaens; Peter M T Pattynama
Journal:  Eur Radiol       Date:  2003-11-14       Impact factor: 5.315

4.  Case report: pulmonary vein stenosis following RF ablation of paroxysmal atrial fibrillation: successful treatment with balloon dilation.

Authors:  J P Moak; H J Moore; S W Lee; T M Giglia; C A Sable; N C Furbush; R R Ringel
Journal:  J Interv Card Electrophysiol       Date:  2000-12       Impact factor: 1.900

5.  Visualization of pulmonary vein stenosis after radio frequency ablation using multi-slice computed tomography: initial clinical experience in 33 patients.

Authors:  Christof Burgstahler; Tobias Trabold; Axel Kuettner; Andreas F Kopp; Christian Mewis; Volker Kuehlkamp; Claus D Claussen; Stephen Schroeder
Journal:  Int J Cardiol       Date:  2005-07-10       Impact factor: 4.164

6.  Clinical presentation, investigation, and management of pulmonary vein stenosis complicating ablation for atrial fibrillation.

Authors:  Douglas L Packer; Paul Keelan; Thomas M Munger; Jerome F Breen; Sam Asirvatham; Laura A Peterson; Kristi H Monahan; Mary F Hauser; K Chandrasekaran; Lawrence J Sinak; David R Holmes
Journal:  Circulation       Date:  2005-02-08       Impact factor: 29.690

7.  Variations in pulmonary venous drainage to the left atrium: implications for radiofrequency ablation.

Authors:  Edith M Marom; James E Herndon; Yun Hyeon Kim; H Page McAdams
Journal:  Radiology       Date:  2004-01-22       Impact factor: 11.105

8.  Technique and results of pulmonary vein angiography in patients undergoing catheter ablation of atrial fibrillation.

Authors:  Chandreaekhar R Vasamreddy; Vinod Jayam; Lars Lickfett; Khurram Nasir; David J Bradley; Zayd Eldadah; Timm Dickfeld; Kevin Donahue; Henry S Halperin; Ronald Berger; Hugh Calkins
Journal:  J Cardiovasc Electrophysiol       Date:  2004-01

9.  Transcatheter angioplasty for acquired pulmonary vein stenosis after radiofrequency ablation.

Authors:  Athar M Qureshi; Lourdes R Prieto; Larry A Latson; Geoffrey K Lane; C Igor Mesia; Penelope Radvansky; Richard D White; Nassir F Marrouche; Eduardo B Saad; Dianna L Bash; Andrea Natale; John F Rhodes
Journal:  Circulation       Date:  2003-09-02       Impact factor: 29.690

10.  Catheter-induced linear lesions in the left atrium in patients with atrial fibrillation: an electroanatomic study.

Authors:  Sabine Ernst; Feifan Ouyang; Felix Löber; Matthias Antz; Karl-Heinz Kuck
Journal:  J Am Coll Cardiol       Date:  2003-10-01       Impact factor: 24.094

View more
  2 in total

Review 1.  The State of the Art in Pulmonary Vein Stenosis -Diagnosis & Treatment.

Authors:  Lourdes R Prieto
Journal:  J Atr Fibrillation       Date:  2010-01-01

Review 2.  Management Of Pulmonary Vein Stenosis Following Catheter Ablation Of Atrial Fibrillation.

Authors:  Narendra Kumar; Ismail Aksoy; Laurent Pison; Carl Timmermans; Jos Maessen; Harry Crijns
Journal:  J Atr Fibrillation       Date:  2014-06-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.